exenatide:exenatide

2 trials

Sponsors

Affiliated Hospital of Nantong University, Peking University Third Hospital

Conditions

Type 2 Diabetic mellitusType 2 diabetes mellitus

Phase 3

A randomized, double-blinded, postive-controlled, multicentered, 16-week study, assessing the effecacy and safeness of exenatide in type 2 diabetes with metformin/secretagogues alone or both

Active, not recruitingChiCTR-IPR-15006558

Peking University Third HospitalType 2 diabetes mellitus

Start: 2011-07-01Updated: 2017-04-18

Phase 4

Intensive Lifestyle Interference for Targeted Body Weight Couple with Different Pharmacal Program in Type 2 Diabetic Patients

RecruitingChiCTR-IPR-15005975

Affiliated Hospital of Nantong UniversityType 2 Diabetic mellitus

Start: 2015-01-26Updated: 2017-04-18

Related Papers

Association of Time in Range with Endothelial Injury in Patients with Type 2 Diabetes Treated with Exenatide.

2022-08-132 citations

High baseline FGF21 levels are associated with poor glucose-lowering efficacy of exenatide in patients with type 2 diabetes.

2021-01-157 citations

Efficacy and safety of generic exenatide injection in Chinese patients with type 2 diabetes: a multicenter, randomized, controlled, non-inferiority trial.

2020-03-234 citations